US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

265.00

-1.0000-0.38%

Volume:170.42K

Turnover:45.79M

Market Cap:496.74M

PE:- -

High:278.96

Open:269.96

Low:262.59

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:1.00

T/O Rate:9.09%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Definitive Healthcare Appoints Clay Ritchey as CEO

Health Care Select Sector SPDR: Pivot points

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference

Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)

uniQure submits biologics license application to FDA for ifezuntirgene inilparvo

Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Hybio Pharmaceutical Co.,Ltd. (300199.SZ) Pingshan Branch Passes US FDA On-Site Inspection

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

uniQure resumed with an Outperform at William Blair

Zhejiang Xianju Pharmaceutical Gets FDA's Abbreviated New Drug Application for Progesterone Vaginal Tablets

MT Newswires Live

Aster DM Quality Care Sets Virtual AGM for September 28, 2026

Health Care Roundup: Market Talk

Wall Street Analysts Are Bullish on Top Healthcare Picks

Nanjing King-Friend Biochemical Pharmaceutical Gets US FDA Nod for Drug Manufacturing Site; Shares Down 5%

MT Newswires Live

Ship Healthcare Advances Share Buyback Program on Tokyo Exchange

Hygeia Healthcare Holdings Co., Ltd. (6078) Gets a Buy from Huatai Securities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":265,"timestamp":1789149809528,"preClose":266,"halted":0,"volume":170415,"delay":0,"changeRate":-0.0037593984962406013,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Trading","change":-1,"latestTime":"09-11 14:03:32 EDT","open":269.9644,"high":278.9613,"low":262.59,"amount":45792333.9405,"amplitude":0.061546,"askPrice":265.75,"askSize":30,"bidPrice":264.77,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003791,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":1.002539,"impliedVol":0.8532,"impliedVolPercentile":0.2151},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.002539,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.061546,"preClose":266,"low":262.59,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":265,"eps":0,"divideRate":0.003791,"volume":170415,"delay":0,"ttmEps":0,"open":269.9644,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664981121","title":"Definitive Healthcare Appoints Clay Ritchey as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981121","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981121?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"Mr. Ritchey brings more than 25 years of deep healthcare expertise to DefinitiveFRAMINGHAM, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355135/0/en/definitive-healthcare-appoints-clay-ritchey-as-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","DH","IXJ","XBI","CGCV","TCAF","BK4550","BK4585","BK4581","XLV","BK4588","VHT","NOBL","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811085","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811085?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:25","pubTimestamp":1788351957,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.60, Pivot Low: $170.10. These were calculated usi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-135?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664112138","title":"SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664112138","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664112138?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:17","pubTimestamp":1788351420,"startTime":"0","endTime":"0","summary":"This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility among key U.S. federal stakeholders, reinforce the clinical and publichealth importance of advancing n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355122/0/en/scisparc-subsidiary-neurothera-labs-pursues-fda-orphan-drug-designation-for-adult-tourette-syndrome-drug-engages-government-and-public-affairs-firm-rk-strategies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819046","title":"Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819046","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819046?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355075/0/en/acrivon-therapeutics-to-present-at-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4588","LENZ","BK4139","XLV","LABU","BK4539","LU0029874061.USD","LU0128526141.USD","BK4585","HCSG","BK4581","BK4007","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819044","title":"Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819044","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819044?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355100/0/en/design-therapeutics-to-participate-in-2026-cantor-fitzgerald-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","LU0029874061.USD","DSGN","BK4505","XLV","BK4139","XBI","BK4581","BK4585","HCSG","LABU","BK4539","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664118518","title":"Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664118518","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664118518?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355096/0/en/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","BK4581","LU0029874061.USD","BK4082","BK4585","BK4137","LABU","XLV","LU0128526141.USD","XBI","BK4588","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819473","title":"Analysts Offer Insights on NA Companies: SpaceX (SPCX) and HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819473?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:50","pubTimestamp":1788349806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on SpaceX (SPCX) and HCA Healthcare (HCA) with bullish sentimen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-spacex-spcx-and-hca-healthcare-hca-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0068578508.USD","SPAX","LOFD","LU1267930490.SGD","XBI","LABU","DXYZ","ORBX","WARP","LOFF","LU2290526834.HKD","HCA","BK4504","SPCU","LU1150488218.USD","SPCX","SPCM","LU1489326972.SGD","BK4588","SPCF","LU0878866978.SGD","IHF","YSPC","LU0130102774.USD","WSPC","ELOL","SPCQ","LU0708994859.HKD","SG9999014013.SGD","BK4089","SPCG","SSPC","XOVR","LU1861220033.SGD","NA","XOVL","SPAL","LU1261432733.SGD","XLV","BK4615","LU2360107168.USD","MARS","SPCH","LU0980610538.SGD","BK4585","SNK","UFO","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819178","title":"uniQure submits biologics license application to FDA for ifezuntirgene inilparvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819178","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819178?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:45","pubTimestamp":1788349557,"startTime":"0","endTime":"0","summary":"uniQure (QURE) announced the submission of a biologics license application, or BLA, to the FDA for the accelerated approval of ifezuntirgene inilpa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-submits-biologics-license-application-to-fda-for-ifezuntirgene-inilparvo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-submits-biologics-license-application-to-fda-for-ifezuntirgene-inilparvo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","QURE","BK4139","LABU","BK4588","LU0320765992.SGD","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664554819","title":"Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664554819","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664554819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"WAYNE, Pa., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commerciali","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355020/0/en/palvella-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","PVLA","XBI","LABU","XLV","LU0128526141.USD","HCSG","LU0029874061.USD","BK4585","BK4581","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150698","title":"uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150698","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150698?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347100,"startTime":"0","endTime":"0","summary":"~ Company also announces the submission of a Marketing Authorisation Application for ifezuntirgene inilparvovec in the U.K. ~ ~ Both submissions are supported by the three-year data analysis from the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354993/0/en/uniqure-announces-submission-of-biologics-license-application-for-ifezuntirgene-inilparvovec-amt-130-in-huntington-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRED","TRUR","ICF","AVRE","DFGR","SPRE","VNQ","XLRE","HELS","BK4534","BK4084","LU0109394709.USD","LU0320765992.SGD","DTCR","LU0889565916.HKD","SRVR","AMT","BK4588","BK4215","BYRE","REAI","DTRE","WTRE","BK4219","BK4139","BK4554","IDGT","BK4585","MAA","FREL","BK4581","GNOM","LABU","PSR","URE","QURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169516845","title":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) Pingshan Branch Passes US FDA On-Site Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1169516845","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169516845?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:56","pubTimestamp":1788346575,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) has announced that its Pingshan branch underwent a routine Current Good Manufacturing Practice (cGMP) inspection by the U.S. Food and Drug Administration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK0188","BK0077","BK4588","LABU","BK0239","BK0028","300199","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673691.USD","LU0234570918.USD","IBB","LU0314106906.USD","LU1506573853.SGD","LU0496365809.HKD","LU1093756325.SGD","SG9999001176.SGD","BK4581","LU0128526141.USD","LU0265550946.USD","LU1291159041.SGD","IE00B894F039.SGD","IE00B3T34201.USD","LU0106261372.USD","XBI","IBBQ","LABU","LU2089283258.USD","XLV","LU1778281490.HKD","IE0009355771.USD","HCSG","GNMX","PBE","LU2456880835.USD","MDT","IE00B19Z3B42.SGD","LU0058720904.USD","IE00B2B36J28.USD","BK4588","BIB","BBH","LU2417539215.USD","LU1057294990.SGD","ALMS","VERX","IDNA","VRTX","TBXU","LU0162691827.USD","BK4533","LU1061106388.HKD","BK4139","IE0002141913.USD","LU1116320901.HKD","LU2112291526.USD","LU0265550359.USD","LU0158827948.USD","LU2023251221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664181516","title":"uniQure resumed with an Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2664181516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664181516?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:45","pubTimestamp":1788345921,"startTime":"0","endTime":"0","summary":"William Blair resumed coverage of uniQure (QURE) with an Outperform rating and $73 fair value estimate. The firm sees a “clearer pathway” to FDA ap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/uniqure-resumed-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/uniqure-resumed-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QURE","LU0889565916.HKD","LABU","ABEQ","BK4585","LU0320765992.SGD","LU0109394709.USD","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664186728","title":"Zhejiang Xianju Pharmaceutical Gets FDA's Abbreviated New Drug Application for Progesterone Vaginal Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664186728","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664186728?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:55","pubTimestamp":1788342919,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration accepted Zhejiang Xianju Pharmaceutical's  abbreviated new drug application for progesterone vaginal tablets, according to a Wednesday filing with the Shenzhen bourse.The tablets help support embryo implantation and early pregnancy by supporting luteal function, according to the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK0239","LABU","BK4585","BK4588","SG9999014674.SGD","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818450","title":"Aster DM Quality Care Sets Virtual AGM for September 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818450?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:54","pubTimestamp":1788342897,"startTime":"0","endTime":"0","summary":"The latest update is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited has announced that its 18th Annual General ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-sets-virtual-agm-for-september-28-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-sets-virtual-agm-for-september-28-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","LABU","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892442","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892442?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:20","pubTimestamp":1788337200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0815 GMT - Novartis's decision to suspend several clinical trial","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4581","LABU","XLV","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0757428866.USD","IBBQ","LU2456880835.USD","LU1585245621.USD","IE00B2B36J28.USD","VRTX","LU0566484027.USD","LU2362540622.SGD","IE00B19Z3581.USD","LU0061475181.USD","LU0234570918.USD","IE00B4R5TH58.HKD","LU1674673428.USD","IE00BZ9MQY76.HKD","BK4533","BBH","IE00B19Z3B42.SGD","SG9999013999.USD","LU2468319806.SGD","BK4137","LU0079474960.USD","IE00B19Z9P08.USD","GNMX","XLV","LU0823416689.USD","LU0320765992.SGD","LU1035775433.USD","IBB","SG9999001176.USD","LU0889565916.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0029874061.USD","LU0109394709.USD","BK4581","PBE","TBXU","VERX","HCSG","LU0432979614.USD","BIB","LU1674673691.USD","LU2324357040.USD","IDNA","LABU","BK4567","LU2417539215.USD","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891417","title":"Nanjing King-Friend Biochemical Pharmaceutical Gets US FDA Nod for Drug Manufacturing Site; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891417","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891417?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:14","pubTimestamp":1788333289,"startTime":"0","endTime":"0","summary":"Nanjing King-Friend Biochemical Pharmaceutical  subsidiary Emerge Bioscience obtained U.S. Food and Drug Administration approval to manufacture adalimumab injection at Kingfriend's manufacturing facility.The biosimilar, sold under the brand YUSIMRY, was originally approved for nine indications including rheumatoid arthritis, Crohn's disease and psoriasis, according to a Wednesday filing with the Shanghai bourse.Shares of the pharmaceutical company declined 5% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK0186","603707","BK4588","LABU","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664289136","title":"Ship Healthcare Advances Share Buyback Program on Tokyo Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2664289136","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664289136?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788332018,"startTime":"0","endTime":"0","summary":"Ship Healthcare Holdings ( ($JP:3360) ) has shared an announcement. Ship Healthcare Holdings has disclosed the acquisition of 525,400 of its own co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-advances-share-buyback-program-on-tokyo-exchange?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-advances-share-buyback-program-on-tokyo-exchange?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4581","XBI","LABU","BK4137","HCSG","BK4585","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664896374","title":"Hygeia Healthcare Holdings Co., Ltd. (6078) Gets a Buy from Huatai Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2664896374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664896374?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:06","pubTimestamp":1788325600,"startTime":"0","endTime":"0","summary":"Huatai Securities analyst maintained a Buy rating on Hygeia Healthcare Holdings Co., Ltd. yesterday and set a price target of HK$18.78. Currently, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/hygeia-healthcare-holdings-co-ltd-6078-gets-a-buy-from-huatai-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/hygeia-healthcare-holdings-co-ltd-6078-gets-a-buy-from-huatai-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4585","XBI","XLV","HCSG","BK4581","BK4137","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":15,"totalSize":417,"code":"91000000","status":"200"}]}}